an adrenal cause is suspected although hormonal tests are recommended as first line.
Results: An abnormal morphology of adrenal was detected in 57.5% of patients. Observed abnormalities were: bilateral hyperplasia (30.6%), unilateral adenoma (15.7%), unilateral hyperplasia (6.7%) and bilateral adenoma (4.5%). Abnormal adrenal hormonal tests were recorded in 16.4% of patients, with a primary aldosteronism (A/R corrected> 23) found in 10.4% and increased urinary cortisol in 6%. Treatment implementation was decided upon morphologic and hormonal results. At 6 months of follow-up, a controlled blood pressure was observed in 73.1% of subjects, spironolactone had been prescribed in 41.8% of subjects and adrenal surgery performed in 3.7% of patients. If hormonal tests had only been performed, a retrospective analysis showed that treatment with spironolactone would have been prescribed only in 12.6% of subjects and an adrenal surgery been proposed only in 2.9% of patients.
Conclusion:
In our population of patients with a resistant hypertension and adrenal disease suspicion, abdominal CT scan as a first line investigation leads directly to the conclusion of an adrenal aetiology in 45.5% of patients. In contrast, a specific treatment would have been undertaken only in 15.5% of patients if screened by hormonal examinations only. This study suggests that in subjects with uncontrolled hypertension and suspected to have an adrenal cause, abdominal CT scan is an efficient first line investigation. Purpose: The purpose of the study was to determine the prognostic significance of vascular markers in apparently healthy subjects.
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Methods:
Analyses were based on the Third South-Western French MONICA Survey (1995) (1996) carried out in participants aged 35-64. Vital status, date and cause of death were obtained 14 years after inclusion. Subjects with a personal history of Atherosclerotic Cardiovascular Disease or with a personal history of Severe Chronic Disease were excluded. Pulse Wave Velocity (PWV), Pulse Pressure (PP), presence of carotid or femoral atherosclerotic plaques, and carotid Intima-Media Thickness (IMT) were assessed. Identification of the determinants of cardiovascular mortality was based on a multivariable survival analysis.
Results: There were 1144 participants (587 (51%) men). Over the 14-year study period, there were 63 deaths, 21% due to a cardiovascular cause (Ischemic Heart Disease, Atherosclerotic Cerebrovascular Disease or Atherosclerosis). The median 10-year risk of coronary event according to the Framingham Risk Score (FRS) was 6.4%. PWV, PP, and carotid or femoral atherosclerotic plaques were all significant and independent determinants of cardiovascular mortality, whereas carotid IMT was no longer associated with cardiovascular mortality after adjustment for FRS. The addition of PWV, PP or atherosclerotic plaques to FRS in a prediction model resulted in an improvement of the discriminatory value of the model as shown by the C-statistic which was 0. Purpose: Our objective was to assess the long term prognosis value of ABI in a contemporary large cohort of pts with known CAD.
Methods. Among 834 consecutive male pts hospitalized in 2001-2004 for coronary artery disease, ABI was measured in 776 pts. ABI -0.9 was considered as abnormal. ABI -0.9 and > 0.6 was considered as low and ABId0.6 as very low. The median follow-up was 7.17 years. Total mortality was predicted with a Cox proportional hazard model.
Results:
Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic, 155 pts (19.8%) were smokers, and median heart rate was 61 bpm [Interquatile range (IQR)] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] . Mean left ventricular ejection fraction was 0.53 (0.13). 88.5% were on antiplatelet therapy, 75.2% on beta-blocker, 66% on statin therapy and 54.8% on ACE inhibitors or ARB.
The sample comprised 518 pts (67%) with normal ABI and 258 (33%) with abnormal ABI (215 (83.3%) pts had a low and 43 (16.7%) a very low ABI). The cumulative seven-year total mortality rate was 17.6%. In the normal ABI group, mortality rate was 13.9%, whereas it was 21.4% in the low and 44.2% in the very low ABI group (p<0.001).
After multivariate adjustment for age, diabetes, tobacco consumption (none; d40 pack-years; >40 pack-years), heart rate, duration of CAD, left ventricular ejection fraction (>0.5; d0.5 and > 0.35; d0.35), history of chronic obstructive pulmonary disease or stroke, statin therapy and coronary revascularization, hazard ratio (HR) for all-cause death was 1.36 (95% CI [0.92; 2.03] p=0.12) for low ABI and 2.48 (95% CI [1.41; 4.36] p=0.002) for very low ABI compared to pts with normal ABI. Including ABI in the prediction model significantly increased the C-statistic (from 0.80 to 0.82, p=0.03).
Conclusion:
ABI is a strong and independent long term predictor factor of all-cause death in CAD. To better identify pts at very high risk, systematic ABI assessment should be promoted. Methods: Study group consisted of 15 pts with angina and NCA (mean age 60,9±5,3 yrs) and 15 age and gender-matched control subjects (normal and hypertensives pts) .
Ascending Ao diameters -derived stiffness indices were: Ao strain, Ao distensibility (Ao dis), Ao stiffness index (Ao SI). Ao function was evaluated also by measuring tissue Doppler (TdI) systolic (SW), early and late diastolic(EW, AW) velocities of the anterior Ao wall. Total afterload was defined by the effective arterial elastance (Ea=0.9XSBP/SV, SV=stroke volume). Systemic vascular resistance index (SVRI)= mean arterial pressure/cardiac index. Total arterial compliance (Ca)=SV/pulse pressure.
